Answers are grounded in this paper and cite their sources.
Retrospective cohort reveals effectiveness of CDK4/6 inhibitors in metastatic breast cancer, suggesting early integration in treatment guidelines.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Bayram et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: